Accessibility Tools

GeoVax Events


October 12, 2023 - 1:30 PM ET

Dawson James Small Cap Growth Conference, Jupiter, FL - webcast

October 4, 2023 - 3:25 PM ET

Emerging Growth Conference - webcast

September 17-20, 2023

Keystone Symposia on Molecular and Cellular Biology, Vaccinology During and After COVID-19, Atlanta, GA - Poster Presentation

September 11, 2023 - 2:30 PM ET

H.C. Wainwright 25th Annual Global Investment Conference, New York, NY  - webcast

September 6, 2023 - 1:45 PM ET

Emerging Growth Conference - webcast

August 9, 2023 - 4:30PM ET

GeoVax Second Quarter 2023 Financial Results and Corporate Update 

Domestic:                    800-715-9871

International:              646-307-1963

Conference ID:           5604173

Webcast:                     GeoVax Earnings Webcast

July 7-8, 2023

AACR-AHNS Head and Neck Cancer Conference, Montréal, QC, Canada - Poster Presentation

June 5-8, 2023

BIO International Convention, Boston, MA

June 2-6, 2023

2023 ASCO Annual Meeting, Chicago, IL

May 23-24, 2023

Alliance Global Partners' Virtual Healthcare Conference

May 20-24, 2023

CYTO 2023, Montreal, Quebec, Canada - Sandra Ortega-Francisco, Ph.D., Department of Hematology and Hematopoietic Cell Transplantation and Hematologic Malignancies Research Institute, City of Hope, participated in a poster presentation titled, “Induction of multi-antigen specific T cell responses by a synthetic MVA-SARS-CoV-2 vaccine in patients with hematological malignancies.”

May 4, 2023

GeoVax First Quarter Earnings Call - webcast

April 30 - May 2, 2023

4th Symposium on Infectious Diseases in the Immunocompromised Host, Seattle, WA 

April 1-4, 2023

World Vaccine Congress, Washington, DC -  Dr. Don Diamond, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope delivered presentation titled  “COVID-19 Vaccine CM04S1; A Superior Viral Platform Alternative for Eliciting Durable T Cell Responses in Immunocompromised Hematologic Malignancy Patients”  
Dr. Jason Comer, Associate Professor, Sealy Institute for Vaccine Sciences, University of Texas Medical Branch (UTMB), delivered presentation titled “Preclinical Capabilities at the University of Texas Medical Branch: Evaluating Candidate Vaccines and Immunotherapeutics against Sudan Ebola Virus,”

March 23, 2023

GeoVax 2022 Earnings 

February 6-9, 2023

BIO CEO & Investor Conference - New York, NY

January 9 - 12, 2023

Biotech Showcase, San Francisco, CA 

Register to receive email alerts for GeoVax press releases
Copyright © GeoVax 2023. All Rights Reserved.